One of the most enduring goals in regenerative medicine is deceptively simple: replace a person's damaged or dying cells with healthy new ones grown in the laboratory.

Longeveron Inc., a biotechnology company focused on regenerative medicine, has licensed a US patent from the University of Miami aimed at developing cardiomyogenic precursor cells from pluripotent ...

Researchers created a nanoparticle-stem cell technology that greatly enhances 3D bone regeneration, advancing treatment for fractures and regenerative medicine. (Nanowerk News) A research team in ...

TORONTO, Oct. 13, 2025 /PRNewswire/ -- Visionary Holdings Inc. ("GV" or the "Company"), a technology-driven multinational enterprise listed on Nasdaq (Nasdaq: GV), today announced that its wholly ...

CAMBRIDGE, England & EDINBURGH, Scotland & ALDERLEY PARK, England--(BUSINESS WIRE)--Axol Bioscience Ltd. (Axol), a leading pluripotent stem cell technology provider for drug discovery has signed an ...

A research team has identified the impact of stem cell infusion timing on the incidence and severity of acute graft-versus-host disease (aGVHD) in allogeneic hematopoietic stem cell transplantation ...

The global stem cell therapy market is entering an era of unprecedented growth and innovation. Valued at $5.13 billion in 2024, the U.S. stem cell market alone is projected to reach $15.79 billion by ...

Leading the commercialization of space-age cellular science for personal care products, Naples Soap Company set to the launch nationally a new personal care product line utilizing NASA’s 3D biometric ...

An international research team with strong participation from DTU has developed a new biotechnological platform that makes it possible to test and understand advanced cancer treatments much faster and ...